{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:40:25Z","timestamp":1790516425511,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T00:00:00Z","timestamp":1284508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,10]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Despite the clinical relevance of anti-factor VIII (FVIII) antibodies (anti-FVIII inhibitors) impairing haemostatic activity of haemophilia A (HA) patients, the immunological mechanisms underlying their production are unknown. Aiming to understand more clearly the immune response in patients with [HA\u03b1-FVIII(+)] and without [HA\u03b1-FVIII(\u2212)] anti-FVIII inhibitors, we have characterized the cytokine pattern of peripheral blood leucocytes, using an in vitro stimulation of whole blood samples with plasma-derived (pFVIII) or recombinant FVIII (rFVIII). The results highlighted decreased levels of tumour necrosis factor (TNF)-\u03b1+ neutrophils with higher interleukin (IL)-5\/TNF-\u03b1 ratio in HA\u03b1-FVIII(+). All HA samples displayed decreased levels of IL-10+ monocytes when compared to the blood donor (BD) samples. HA\u03b1-FVIII(+) showed lower levels of TNF-\u03b1+ monocytes and increased IL-10\/TNF-\u03b1 ratio. Analysis of adaptive immunity revealed increased levels of interferon (IFN)-\u03b3+, TNF-\u03b1+ and IL-4+ T-cells, from both CD4+ and CD8+ T cells, in HA\u03b1-FVIII(\u2212) when compared to BD. Moreover, increased frequency of IL-10+ B cells and higher levels of \u03b1-FVIII IgG1 were observed in HA\u03b1-FVIII(\u2212). Basal levels of cytokine+ B-cells, similar to BD, and higher levels of \u03b1-FVIII IgG4 are major features in HA\u03b1-FVIII(+). The global cytokine profile demonstrated a major anti-inflammatory\/regulatory pattern in HA\u03b1-FVIII(+), confirmed by the in vitro stimuli with pFVIII or rFVIII. The polarized anti-inflammatory\/regulatory immune response in HA\u03b1-FVIII(+) and the mixed pattern with a bias towards an inflammatory cytokine profile, modulated by IL-4 in HA\u03b1-FVIII(\u2212), may be the key element to drive the development of distinct subclasses of anti-FVIII antibodies. These finding have implications for the design of safe and effective therapeutic protocols to control inhibitors synthesis in HA patients.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2010.04258.x","type":"journal-article","created":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T20:02:00Z","timestamp":1284580920000},"page":"425-437","source":"Crossref","is-referenced-by-count":23,"title":["A shift towards a T cell cytokine deficiency along with an anti-inflammatory\/regulatory microenvironment may enable the synthesis of anti-FVIII inhibitors in haemophilia A patients"],"prefix":"10.1093","volume":"162","author":[{"given":"D G","family":"Chaves","sequence":"first","affiliation":[{"name":"Departamento de Bioqu\u00edmica e Imunologia, Universidade Federal de Minas Gerais"},{"name":"Laborat\u00f3rio de Pesquisa, Funda\u00e7\u00e3o HEMOMINAS"},{"name":"Laborat\u00f3rio de Biomarcadores de Diagn\u00f3stico e Monitora\u00e7\u00e3o, Instituto Ren\u00e9 Rachou, Funda\u00e7\u00e3o Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Velloso-Rodrigues","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Pesquisa, Funda\u00e7\u00e3o HEMOMINAS"},{"name":"Pontif\u00edcia Universidade Cat\u00f3lica de Minas Gerais"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Pesquisa, Funda\u00e7\u00e3o HEMOMINAS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Biomarcadores de Diagn\u00f3stico e Monitora\u00e7\u00e3o, Instituto Ren\u00e9 Rachou, Funda\u00e7\u00e3o Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Santoro","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica e Imunologia, Universidade Federal de Minas Gerais"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O A","family":"Martins-Filho","sequence":"additional","affiliation":[{"name":"Departamento de Bioqu\u00edmica e Imunologia, Universidade Federal de Minas Gerais"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,9,15]]},"reference":[{"key":"2021122708484090700_b1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0140-6736(92)90874-3","article-title":"Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs","volume":"339","author":"Ehrenforth","year":"1992","journal-title":"Lancet"},{"key":"2021122708484090700_b2","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1182\/blood.V95.4.1324.004k25_1324_1329","article-title":"Prevention and treatment of factor VIII inhibitors in murine hemophilia A","volume":"95","author":"Qian","year":"2000","journal-title":"Blood"},{"key":"2021122708484090700_b3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1160\/TH06-09-0519","article-title":"Cytokine production by CD4+ T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients","volume":"97","author":"Hu","year":"2007","journal-title":"Thromb Haemost"},{"key":"2021122708484090700_b4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0038-1650515","article-title":"T lymphocyte proliferative responses induced by recombinant factor VIII in hemophilia A patients with inhibitors","volume":"76","author":"Singer","year":"1996","journal-title":"Thromb Haemost"},{"key":"2021122708484090700_b5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1055\/s-0037-1615873","article-title":"CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjects","volume":"82","author":"Reding","year":"1999","journal-title":"Thromb Haemost"},{"key":"2021122708484090700_b6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1055\/s-0037-1614081","article-title":"Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects","volume":"84","author":"Reding","year":"2000","journal-title":"Thromb Haemost"},{"key":"2021122708484090700_b7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1055\/s-0037-1613257","article-title":"Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients","volume":"88","author":"Reding","year":"2002","journal-title":"Thromb Haemost"},{"key":"2021122708484090700_b8","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1046\/j.1538-7836.2003.00366.x","article-title":"Recognition of coagulation factor VIII by CD4+ T cells of healthy humans","volume":"1","author":"Hu","year":"2003","journal-title":"J Thromb Haemost"},{"key":"2021122708484090700_b9","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2006-05-024711","article-title":"Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A","volume":"108","author":"Astermark","year":"2006","journal-title":"Blood"},{"key":"2021122708484090700_b10","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2005-09-3918","article-title":"Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A","volume":"107","author":"Astermark","year":"2006","journal-title":"Blood"},{"key":"2021122708484090700_b11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1744-313X.2009.00893.x","article-title":"Analysis of cytokine genes polymorphism as markers for inhibitor development in haemophilia A","volume":"37","author":"Chaves","year":"2010","journal-title":"Int J Immunogenet"},{"key":"2021122708484090700_b12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2249.2006.03171.x","article-title":"Mixed inflammatory\/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection","volume":"146","author":"Peruhype-Magalh\u00e3es","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"2021122708484090700_b13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood.V95.3.820.003k32_820_828","article-title":"Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector","volume":"95","author":"Balagu\u00e9","year":"2000","journal-title":"Blood"},{"key":"2021122708484090700_b14","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199227396.001.0001","volume-title":"Oxford handbook of clinical haematology","author":"Provan","year":"2009","edition":"3nd"},{"key":"2021122708484090700_b15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-3083.2008.02167.x","article-title":"Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease","volume":"68","author":"Vitelli-Avelar","year":"2008","journal-title":"Scand J Immunol"},{"key":"2021122708484090700_b16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1160\/TH05-08-0559","article-title":"Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitution","volume":"95","author":"Bril","year":"2006","journal-title":"Thromb Haemost"},{"key":"2021122708484090700_b17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2141.2008.07232.x","article-title":"IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A","volume":"142","author":"Van Helden","year":"2008","journal-title":"Br J Haematol"},{"key":"2021122708484090700_b18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1365-2141.2008.07043.x","article-title":"Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains","volume":"141","author":"Chaves","year":"2008","journal-title":"Br J Haematol"},{"key":"2021122708484090700_b19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2516.2006.01363.x","article-title":"Immunological aspects of inhibitor development","volume":"12","author":"Reding","year":"2006","journal-title":"Haemophilia"},{"key":"2021122708484090700_b20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2006-946909","article-title":"Inhibitor development in hemophiliacs: the roles of genetic versus environmental factors","volume":"32","author":"Lee","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"2021122708484090700_b21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2516.2008.01694.x","article-title":"Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations","volume":"14","author":"Boekhorst","year":"2008","journal-title":"Haemophilia"},{"key":"2021122708484090700_b22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1655944","article-title":"HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A.","volume":"77","author":"Hay","year":"1997","journal-title":"Thromb Haemost"},{"key":"2021122708484090700_b23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1655945","article-title":"HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII","volume":"77","author":"Oldenburg","year":"1997","journal-title":"Thromb Haemost"},{"key":"2021122708484090700_b24","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.4049\/jimmunol.174.8.4718","article-title":"Regulatory-1 cells induce IgG4 production by B cells: role of IL-10","volume":"174","author":"Satoguina","year":"2005","journal-title":"J Immunol"},{"key":"2021122708484090700_b25","first-page":"1040","article-title":"A theory of self-nonself discrimination","volume":"169","author":"Bretcher","year":"1970","journal-title":"Science"},{"key":"2021122708484090700_b26","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood-2009-01-200725","article-title":"Lineages of human T-cell clones, including T helper 17\/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses","volume":"114","author":"Ettinger","year":"2009","journal-title":"Blood"},{"key":"2021122708484090700_b27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1084\/jem.179.2.757","article-title":"Human interleukin 10 induces naive surface immunoglobulin D+ (slgD) B cells to secrete IgG1 and IgG3","volume":"179","author":"Bri\u00e8re","year":"1994","journal-title":"J Exp Med"},{"key":"2021122708484090700_b28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T cell lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2010.04258.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/162\/3\/425\/41924556\/j.1365-2249.2010.04258.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/162\/3\/425\/41924556\/j.1365-2249.2010.04258.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:23:06Z","timestamp":1641054186000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/162\/3\/425\/6438625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,15]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,9,15]]},"published-print":{"date-parts":[[2010,11,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04258.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,12]]},"published":{"date-parts":[[2010,9,15]]}}}